Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
3 Biotech Blockbusters to Turn $5,000 Into $50,000
12:48pm, Tuesday, 12'th Sep 2023
Investing in biotech stock can provide investors with immense rewards but also substantial risks. The key is finding the right balance.
Bears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now
03:26pm, Tuesday, 15'th Aug 2023
After losing some value lately, a hammer chart pattern has been formed for VAXART, INC. (VXRT), indicating that the stock has found support.
Vaxart, Inc. (VXRT) Q2 2023 Earnings Call Transcript
07:40pm, Thursday, 03'rd Aug 2023
Start Time: 16:30 January 1, 0000 5:01 PM ET Vaxart, Inc. (NASDAQ:VXRT ) Q2 2023 Earnings Conference Call August 03, 2023, 16:30 PM ET Company Participants Andrei Floroiu - President and CEO James Cum
VAXART, INC. (VXRT) Reports Q2 Loss, Tops Revenue Estimates
06:46pm, Thursday, 03'rd Aug 2023
VAXART, INC. (VXRT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19.
Why Is Vaxart (VXRT) Stock Down 25% Today?
09:29am, Wednesday, 07'th Jun 2023
Vaxart (NASDAQ: VXRT ) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering. According to a press release from Vaxart, the company is ho
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
05:30am, Monday, 24'th Apr 2023
Novavax and Vaxart both were early favorites in the coronavirus vaccine race -- but the two companies fell behind. Since then, they've cut costs and shifted strategies.
Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus
08:00am, Friday, 17'th Mar 2023
Company to provide a detailed overview of its norovirus clinical program
Vaxart, Inc. (VXRT) Q4 2022 Earnings Call Transcript
08:51pm, Wednesday, 15'th Mar 2023
Vaxart, Inc. (NASDAQ:VXRT ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Brant Biehn - Senior Vice President, Business Operations Andrei Floroiu - Chief Executive Of
Vaxart to Host Full Year 2022 Business Update and Financial Results Conference Call on March 15
04:05pm, Wednesday, 08'th Mar 2023
Conference call to begin at 4:30 p.m. ET
Best Penny Stocks To Buy? 4 To Watch Before 2023
02:07pm, Thursday, 29'th Dec 2022
Penny stocks to watch before next year. The post Best Penny Stocks To Buy?
Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29
08:30am, Tuesday, 22'nd Nov 2022
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine
Vaxart, Inc. (VXRT) Q3 2022 Earnings Call Transcript
07:50pm, Tuesday, 08'th Nov 2022
Vaxart, Inc. (NASDAQ:VXRT ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Brant Biehn - SVP, Business Operations Cezar Floroiu - CEO, President & Director Sean Tuck
VAXART, INC. (VXRT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:18am, Tuesday, 01'st Nov 2022
VAXART, INC. (VXRT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
3 Supercharged Growth Stocks With 257% to 379% Upside, According to Wall Street
05:06am, Tuesday, 25'th Oct 2022
Select analysts believe these industry game changers can skyrocket over the next year.
Vaxart to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 8
08:30am, Thursday, 20'th Oct 2022
Conference call to begin at 4:30 p.m. ET
